Annual Total Long Term Liabilities
$768.40 K
-$521.30 K-40.42%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual total long term liabilities is $768.40 thousand, with the most recent change of -$521.30 thousand (-40.42%) on December 31, 2023.
- During the last 3 years, COEP annual total long term liabilities has risen by +$603.70 thousand (+366.55%).
- COEP annual total long term liabilities is now -53.43% below its all-time high of $1.65 million, reached on December 31, 2021.
Performance
COEP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$533.30 K
-$349.50 K-39.59%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly total long term liabilities is $533.30 thousand, with the most recent change of -$349.50 thousand (-39.59%) on September 1, 2024.
- Over the past year, COEP quarterly long term liabilities has dropped by -$235.10 thousand (-30.60%).
- COEP quarterly long term liabilities is now -80.08% below its all-time high of $2.68 million, reached on March 31, 2023.
Performance
COEP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
COEP Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -40.4% | -30.6% |
3 y3 years | +366.6% | +158.5% |
5 y5 years | +366.6% | +158.5% |
COEP Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -53.4% | at low | -80.1% | +158.5% |
5 y | 5-year | -53.4% | +366.6% | -80.1% | +158.5% |
alltime | all time | -53.4% | +366.6% | -80.1% | +158.5% |
Coeptis Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $533.30 K(-39.6%) |
Jun 2024 | - | $882.80 K(+20.3%) |
Mar 2024 | - | $733.60 K(-4.5%) |
Dec 2023 | $768.40 K(-40.4%) | $768.40 K(+41.5%) |
Sep 2023 | - | $543.10 K(-74.8%) |
Jun 2023 | - | $2.15 M(-19.6%) |
Mar 2023 | - | $2.68 M(+107.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $1.29 M(-21.8%) | $1.29 M(+525.2%) |
Sep 2022 | - | $206.30 K(0.0%) |
Jun 2022 | - | $206.30 K(-87.9%) |
Mar 2022 | - | $1.71 M(+3.4%) |
Dec 2021 | $1.65 M(+901.8%) | - |
Dec 2021 | - | $1.65 M |
Dec 2020 | $164.70 K | - |
FAQ
- What is Coeptis Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual total long term liabilities year-on-year change?
- What is Coeptis Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly long term liabilities year-on-year change?
What is Coeptis Therapeutics annual total long term liabilities?
The current annual total long term liabilities of COEP is $768.40 K
What is the all time high annual total long term liabilities for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual total long term liabilities is $1.65 M
What is Coeptis Therapeutics annual total long term liabilities year-on-year change?
Over the past year, COEP annual total long term liabilities has changed by -$521.30 K (-40.42%)
What is Coeptis Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of COEP is $533.30 K
What is the all time high quarterly long term liabilities for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly total long term liabilities is $2.68 M
What is Coeptis Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, COEP quarterly total long term liabilities has changed by -$235.10 K (-30.60%)